SCHEMBL6027574

SCHEMBL6027574

O=Cc1c(O)cccc1OCc1cccc(C(=O)O)c1

nearest known ligand 0.60

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MRGPRX4 Q96LA9 16/20 0.60
MEN1 O00255 1/20 0.60
NPC1 O15118 1/20 0.60
MITF O75030 1/20 0.60
TP53 P04637 1/20 0.60
HPGD P15428 1/20 0.60
XBP1 P17861 1/20 0.60
NFKB1 P19838 1/20 0.60
RAB9A P51151 1/20 0.60
NFKB2 Q00653 1/20 0.60
KMT2A Q03164 1/20 0.60
RELA Q04206 1/20 0.60
SMN1; SMN2 Q16637 1/20 0.60
FOLH1 Q04609 1/20 0.56
RXRA P19793 1/20 0.54
RXRB P28702 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tucaresol SCHEMBL600942 0.86 RXRA (0.56) MRGPRX4NPC1HPGDRAB9AKMT2A
Tucaresol SCHEMBL29400654 0.86 RXRA (0.56) MRGPRX4NPC1HPGDRAB9AKMT2A
SCHEMBL6027093 0.86 MRGPRX4 (0.55) MRGPRX4NPC1HPGDRAB9ASMN1; SMN2
SCHEMBL2370214 0.84 MAPT (0.57) NPC1RAB9ASMN1; SMN2FOLH1
SCHEMBL31482098 0.81 MRGPRX4 (0.67) MRGPRX4MEN1NPC1MITFTP53
SCHEMBL18630426 0.81 F2 (0.45) MRGPRX4MEN1NPC1MITFTP53
SCHEMBL30078103 0.79 MRGPRX4 (0.60) MRGPRX4MEN1NPC1MITFTP53
SCHEMBL15065649 0.79 MRGPRX4 (0.60) MRGPRX4MEN1NPC1MITFTP53
SCHEMBL23383954 0.77 MAOB (0.53) RAB9AKMT2ASMN1; SMN2RXRARXRB
SCHEMBL6026854 0.77 TP53 (0.58) MRGPRX4MEN1TP53HPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7074770-B1 Method of DNA vaccination SMITHKLINE BEECHAM CORPORATION (US) 2006-07-11 US claimed
EP-1107785-A1 METHOD OF DNA VACCINATION GLAXO GROUP LIMITED (GB) 2001-06-20 EP claimed
WO-2000012121-A1 METHOD OF DNA VACCINATION GLAXO GROUP LIMITED (GB) 2000-03-09 WO claimed
US-4410537-A 3-HYDROXY-2-FORMYLPHENOXYPENTANOIC ACID DERIVATIVES BURROUGHTS WELLCOME CO. (US) 1983-10-18 US claimed
EP-0022229-B1 SUBSTITUTED PHENOL ETHERS, THEIR PREPARATION, INTERMEDIATES THEREFOR, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THE PREPARATION THEREOF THE WELLCOME FOUNDATION LIMITED (GB) 1982-12-08 EP claimed
EP-0022229-A1 Substituted phenol ethers, their preparation, intermediates therefor, pharmaceutical compositions containing them and the preparation thereof THE WELLCOME FOUNDATION LIMITED (GB) 1981-01-14 EP claimed
US-7074770-B1 Method of DNA vaccination SMITHKLINE BEECHAM CORPORATION (US) 2006-07-11 US disclosed
EP-1107785-A1 METHOD OF DNA VACCINATION GLAXO GROUP LIMITED (GB) 2001-06-20 EP disclosed
WO-2000012121-A1 METHOD OF DNA VACCINATION GLAXO GROUP LIMITED (GB) 2000-03-09 WO disclosed
EP-0614357-A1 IMMUNOPOTENTIATORY AGENTS THE WELLCOME FOUNDATION LIMITED (GB) 1994-09-14 EP disclosed
WO-1994007479-A2 IMMUNOPOTENTIATORY AGENTS THE WELLCOME FOUNDATION LIMITED (GB) 1994-04-14 WO disclosed
US-4410537-A 3-HYDROXY-2-FORMYLPHENOXYPENTANOIC ACID DERIVATIVES BURROUGHTS WELLCOME CO. (US) 1983-10-18 US disclosed
EP-0022229-B1 SUBSTITUTED PHENOL ETHERS, THEIR PREPARATION, INTERMEDIATES THEREFOR, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THE PREPARATION THEREOF THE WELLCOME FOUNDATION LIMITED (GB) 1982-12-08 EP disclosed
EP-0022229-A1 Substituted phenol ethers, their preparation, intermediates therefor, pharmaceutical compositions containing them and the preparation thereof THE WELLCOME FOUNDATION LIMITED (GB) 1981-01-14 EP disclosed